Repurposing of rutin for the inhibition of norovirus replication

Archives of Virology

Volumn 160, Issue 9, 2015, Pages 2353-2358

  Chéron, Nicolas ^a   Yu, Chenchen ^b   Kolawole, Abimbola O ^b   Shakhnovich, Eugene I ^a   Wobus, Christiane E ^b  

^a HARVARD UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MURINE NOROVIRUS; NOROVIRUS;

ANTIVIRUS AGENT; RUTOSIDE;

ANIMAL; CELL LINE; CELL SURVIVAL; DRUG EFFECTS; DRUG REPOSITIONING; MACROPHAGE; MOUSE; NOROVIRUS; PHYSIOLOGY; VIROLOGY; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CELL SURVIVAL; DRUG REPOSITIONING; MACROPHAGES; MICE; NOROVIRUS; RUTIN; VIRUS REPLICATION;

EID: 84940459100     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-015-2495-y     Document Type: Article

References (49)

1. Arias A, Emmott E, Vashist S, Goodfellow I (2013) Progress towards the prevention and treatment of norovirus infections. Futur Microbiol 8:1475–1487
2. Blanton LH, Adams SM, Beard RS, Wei G, Bulens SN, Widdowson MA, Glass RI, Monroe SS (2006) Molecular and epidemiologic trends of caliciviruses associated with outbreaks of acute gastroenteritis in the United States, 2000–2004. J Infect Dis 193:413–421
3. Butler M, Ng CY, van Heel DA, Lombardi G, Lechler R, Playford RJ, Ghosh S (2006) Modulation of dendritic cell phenotype and function in an in vitro model of the intestinal epithelium. Eur J Immunol 36:864–874
4. Chang KO, Takahashi D, Prakash O, Kim Y (2012) Characterization and inhibition of norovirus proteases of genogroups I and II using a fluorescence resonance energy transfer assay. Virology 423:125–133
5. Cho AE, Guallar V, Berne BJ, Friesner R (2005) Importance of accurate charges in molecular docking: quantum mechanical/molecular mechanical (QM/MM) approach. J Comput Chem 26:915–931
6. Costantini VP, Whitaker T, Barclay L, Lee D, McBrayer TR, Schinazi RF, Vinje J (2012) Antiviral activity of nucleoside analogues against norovirus. Antiviral Ther 17:981–991
7. Deschner EE, Ruperto JF, Wong GY, Newmark HL (1993) The effect of dietary quercetin and rutin on AOM-induced acute colonic epithelial abnormalities in mice fed a high-fat diet. Nutr Cancer 20:199–204
8. Dhanak D, Duffy KJ, Johnston VK, Lin-Goerke J, Darcy M, Shaw AN, Gu B, Silverman C, Gates AT, Nonnemacher MR, Earnshaw DL, Casper DJ, Kaura A, Baker A, Greenwood C, Gutshall LL, Maley D, DelVecchio A, Macarron R, Hofmann GA, Alnoah Z, Cheng HY, Chan G, Khandekar S, Keenan RM, Sarisky RT (2002) Identification and biological characterization of heterocyclic inhibitors of the hepatitis C virus RNA-dependent RNA polymerase. J Biol Chem 277:38322–38327
9. Duizer E, Schwab KJ, Neill FH, Atmar RL, Koopmans MP, Estes MK (2004) Laboratory efforts to cultivate noroviruses. J Gen Virol 85:79–87
10. Feng X, Jiang X (2007) Library screen for inhibitors targeting norovirus binding to histo-blood group antigen receptors. Antimicrob Agents Chemother 51:324–331
11. Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK, Shaw DE, Francis P, Shenkin PS (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47:1739–1749
12. Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, Sanschagrin PC, Mainz DT (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 49:6177–6196
13. Gonzalez-Hernandez MB, Bragazzi Cunha J, Wobus CE (2012) Plaque assay for murine norovirus. J Vis Exp 66:e4297
14. Gonzalez-Hernandez MJ, Pal A, Gyan KE, Charbonneau M-E, Showalter HD, Donato NJ, O’Riordan M, Wobus CE (2014) Chemical derivatives of a small molecule deubiquitinase inhibitor have antiviral activity against several RNA viruses. PLoS ONE 9:e94491
15. Green KY (2014) Norovirus infection in immunocompromised hosts. Clin Microbiol Infect 20:717–723
16. Guardia T, Rotelli AE, Juarez AO, Pelzer LE (2001) Anti-inflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. Il Farmaco 56:683–687
17. Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, Pollard WT, Banks JL (2004) Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 47:1750–1759
18. Hall AJ, Lopman BA, Payne DC, Patel MM, Gastanaduy PA, Vinje J, Parashar UD (2013) Norovirus disease in the United States. Emerg Infect Dis 19:1198–1205
19. Irwin JJ, Shoichet BK (2005) ZINC—a free database of commercially available compounds for virtual screening. J Chem Inf Model 45:177–182
20. Irwin JJ, Sterling T, Mysinger MM, Bolstad ES, Coleman RG (2012) ZINC: a free tool to discover chemistry for biology. J Chem Inf Model 52:1757–1768
21. Karst SM, Wobus CE, Goodfellow IG, Green KY, Virgin HW (2014) Advances in norovirus biology. Cell Host Microbe 15:668–680
22. Kim Y, Lovell S, Tiew KC, Mandadapu SR, Alliston KR, Battaile KP, Groutas WC, Chang KO (2012) Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses. J Virol 86:11754–11762
23. Kinch MS, Haynesworth A, Kinch SL, Hoyer D (2014) An overview of FDA-approved new molecular entities: 1827–2013. Drug Discov Today 19:1033–1039
24. Kroneman A, Vega E, Vennema H, Vinje J, White PA, Hansman G, Green K, Martella V, Katayama K, Koopmans M (2013) Proposal for a unified norovirus nomenclature and genotyping. Arch Virol 158:2059–2068
25. Laufer S, Holzgrabe U, Steinhilber D (2013) Drug discovery: a modern decathlon. Angew Chem Int Ed Engl 52:4072–4076
26. Lin JP, Yang JS, Lu CC, Chiang JH, Wu CL, Lin JJ, Lin HL, Yang MD, Liu KC, Chiu TH, Chung JG (2009) Rutin inhibits the proliferation of murine leukemia WEHI-3 cells in vivo and promotes immune response in vivo. Leuk Res 33:823–828
27. Lin YJ, Chang YC, Hsiao NW, Hsieh JL, Wang CY, Kung SH, Tsai FJ, Lan YC, Lin CW (2012) Fisetin and rutin as 3C protease inhibitors of enterovirus A71. J Virol Methods 182:93–98
28. Mandadapu SR, Weerawarna PM, Gunnam MR, Alliston KR, Lushington GH, Kim Y, Chang KO, Groutas WC (2012) Potent inhibition of norovirus 3CL protease by peptidyl alpha-ketoamides and alpha-ketoheterocycles. Bioorg Med Chem Lett 22:4820–4826
29. Mastrangelo E, Pezzullo M, Tarantino D, Petazzi R, Germani F, Kramer D, Robel I, Rohayem J, Bolognesi M, Milani M (2012) Structure-based inhibition of norovirus RNA-dependent RNA polymerases. J Mol Biol 419:198–210
30. Mullard A (2012) Drug repurposing programmes get lift off. Nat Rev Drug Discov 11:505–506
31. Ng KK, Pendas-Franco N, Rojo J, Boga JA, Machin A, Alonso JM, Parra F (2004) Crystal structure of norwalk virus polymerase reveals the carboxyl terminus in the active site cleft. J Biol Chem 279:16638–16645
32. Patel MM, Widdowson MA, Glass RI, Akazawa K, Vinje J, Parashar UD (2008) Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis 14:1224–1231
33. Rademacher C, Guiard J, Kitov PI, Fiege B, Dalton KP, Parra F, Bundle DR, Peters T (2011) Targeting norovirus infection-multivalent entry inhibitor design based on NMR experiments. Chemistry 17:7442–7453
34. Reuters T (2012) Knowledge-based drug repositioning to drive R&D productivity. White paper. Thompson Reuters
35. Riggs BL, Hartmann LC (2003) Selective estrogen-receptor modulators—mechanisms of action and application to clinical practice. N Engl J Med 348:618–629
36. Rocha-Pereira J, Cunha R, Pinto DC, Silva AM, Nascimento MS (2010) (E)-2-styrylchromones as potential anti-norovirus agents. Bioorg Med Chem 18:4195–4201
37. Rocha-Pereira J, Jochmans D, Debing Y, Verbeken E, Nascimento MS, Neyts J (2013) The viral polymerase inhibitor 2’-C-methylcytidine inhibits Norwalk virus replication and protects against norovirus-induced diarrhea and mortality in a mouse model. J Virol 87:11798–11805
38. Sardana D, Zhu C, Zhang M, Gudivada RC, Yang L, Jegga AG (2011) Drug repositioning for orphan diseases. Brief Bioinform 12:346–356
39. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, Jones JL, Griffin PM (2011) Foodborne illness acquired in the United States—major pathogens. Emerg Infect Dis 17:7–15
40. Subba-Reddy CV, Goodfellow I, Kao CC (2011) VPg-primed RNA synthesis of norovirus RNA-dependent RNA polymerases by using a novel cell-based assay. J Virol 85:13027–13037
41. Thackray LB, Wobus CE, Chachu KA, Liu B, Alegre ER, Henderson KS, Kelley ST, Virgin HW IV (2007) Murine noroviruses comprising a single genogroup exhibit biological diversity despite limited sequence divergence. J Virol 81:10460–10473
42. Tiew KC, He G, Aravapalli S, Mandadapu SR, Gunnam MR, Alliston KR, Lushington GH, Kim Y, Chang KO, Groutas WC (2011) Design, synthesis, and evaluation of inhibitors of Norwalk virus 3C protease. Bioorg Med Chem Lett 21:5315–5319
43. Treanor JJ, Atmar RL, Frey SE, Gormley R, Chen WH, Ferreira J, Goodwin R, Borkowski A, Clemens R, Mendelman PM (2014) A novel intramuscular bivalent norovirus virus-like particle vaccine candidate-reactogenicity, safety, and immunogenicity in a phase 1 trial in healthy adults. J Infect Dis 210:1763–1771
44. Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, Bevers TB, Fehrenbacher L, Pajon ER Jr, Wade JL 3rd, Robidoux A, Margolese RG, James J, Lippman SM, Runowicz CD, Ganz PA, Reis SE, McCaskill-Stevens W, Ford LG, Jordan VC, Wolmark N, National Surgical Adjuvant B, Bowel P (2006) Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 295:2727–2741
45. Wobus CE, Karst SM, Thackray LB, Chang KO, Sosnovtsev SV, Belliot G, Krug A, Mackenzie JM, Green KY, Virgin HW (2004) Replication of Norovirus in cell culture reveals a tropism for dendritic cells and macrophages. PLoS Biol 2:e432
46. Xu K, Cote TR (2011) Database identifies FDA-approved drugs with potential to be repurposed for treatment of orphan diseases. Brief Bioinform 12:341–345
47. Yanga J, Juan Guoa J, Yuan J (2008) In vitro antioxidant properties of rutin. LWT Food Sci Technol 41:1060–1066
48. Yunus MA, Lin X, Bailey D, Karakasiliotis I, Chaudhry Y, Vashist S, Zhang G, Thorne L, Kao CC, Goodfellow I (2015) The murine norovirus core subgenomic RNA promoter consists of a stable stem-loop that can direct accurate initiation of RNA synthesis. J Virol 89:1218–1229
49. Zamyatkin DF, Parra F, Alonso JM, Harki DA, Peterson BR, Grochulski P, Ng KK (2008) Structural insights into mechanisms of catalysis and inhibition in Norwalk virus polymerase. J Biol Chem 283:7705–7712